Malformacja chiari
Epidemiologia

Malformacja Chiari typu I (MC-I) to wrodzona anomalia anatomiczna charakteryzująca się przemieszczeniem migdałków móżdżku o co najmniej 5 mm poniżej otworu wielkiego czaszki, z częstością występowania w populacji ogólnej szacowaną na 0,1-3,6%, przy około 1% wykrywalności w badaniach MRI u zdrowych dorosłych. Objawowa MC-I jest rzadsza, z częstością 0,01-0,04% u dorosłych i 7:100 000 u dzieci. Występuje dwufazowy szczyt zachorowań – we wczesnym dzieciństwie (8-9 lat) oraz u dorosłych (41-46 lat), z wyraźną przewagą kobiet (stosunek 3:1) w populacji dorosłych. Współwystępowanie syringomielii obserwuje się u 20-56% pacjentów z MC-I, a wodogłowie u 7-10%, co ma znaczenie prognostyczne i wpływa na ryzyko powikłań po leczeniu chirurgicznym. Malformacja Chiari typu II niemal zawsze współistnieje z przepukliną oponowo-rdzeniową (95-100% przypadków), a jej częstość zmniejsza się dzięki profilaktyce prenatalnej, np. suplementacji kwasem foliowym.

Epidemiologia Malformacji Chiari

Malformacja Chiari (MC) to wrodzona anomalia anatomiczna charakteryzująca się przemieszczeniem migdałków móżdżku w kierunku otworu wielkiego czaszki i górnej części kanału kręgowego. Mimo że choroba ta została opisana ponad wiek temu, jej rzeczywista częstość występowania pozostaje przedmiotem badań i debat w środowisku medycznym.12

Rozpowszechnienie Malformacji Chiari w populacji

Rzeczywista częstość występowania malformacji Chiari w populacji ogólnej pozostaje trudna do precyzyjnego określenia, głównie ze względu na znaczącą liczbę przypadków bezobjawowych oraz różnice w kryteriach diagnostycznych stosowanych w badaniach epidemiologicznych.12

Według różnych badań szacuje się, że rozpowszechnienie malformacji Chiari typu I (MC-I), który jest najczęstszym typem, wynosi od 0,1% do 3,6% populacji ogólnej.123 Badania wykorzystujące rezonans magnetyczny (MRI) wskazują, że około 1% zdrowych dorosłych poddanych badaniu MRI wykazuje przemieszczenie migdałków móżdżku o co najmniej 5 mm poniżej otworu wielkiego, co spełnia radiologiczne kryteria rozpoznania MC-I.1 W populacji pediatrycznej odsetek ten może być wyższy i sięgać nawet 3,6%.1

Częstość występowania objawowej malformacji Chiari I jest znacznie niższa i szacuje się ją na około 0,01-0,04% dorosłych.12 Jedno z badań pediatrycznych oszacowało częstość występowania objawowej MC-I na 7:100 000 dzieci.1

Trendy czasowe i regionalne różnice epidemiologiczne

W ciągu ostatniej dekady obserwuje się wzrost liczby diagnozowanych przypadków malformacji Chiari I. Według niektórych danych, częstość diagnozowania MC-I wzrosła z 45 do 96 przypadków na 100 000 osób w latach 2003-2012.1 Ten wzrost przypisuje się głównie powszechnemu stosowaniu obrazowania metodą rezonansu magnetycznego, które umożliwia wykrycie bezobjawowych przypadków.12

Występowanie malformacji Chiari wykazuje znaczne zróżnicowanie geograficzne i etniczne. Interesującym przykładem jest populacja Tatarów w regionie Wołga-Ural w Rosji, gdzie odnotowano wyjątkowo wysoką częstość występowania syringomielii związanej z malformacją Chiari – do 130 przypadków na 100 000 mieszkańców.1 W Republice Tatarstanu w Federacji Rosyjskiej przeprowadzone badanie wykazało, że częstość występowania objawowej malformacji Chiari I wynosiła 20:100 000 osób, a w niektórych regionach północnych, jak rejon Baltasy, sięgała nawet 413:100 000.1

We Włoszech badania Ciaramitaro i współpracowników wykazały, że częstość występowania malformacji Chiari wynosi 7,74 na 100 000 osób (95% CI: 6,965-8,596), a zachorowalność 3,08 na 100 000 osób (95% CI: 2,605-3,635).1

Region geograficzny Częstość występowania (na 100 000 mieszkańców) Źródło
Japonia 1,94 Sakushima et al. (2012)
USA 7 Kurtzke (1996)
Nowa Zelandia 8,2 Brickell et al. (2006)
Tatarstan, Rosja 12,6 Dane autorów (2011)
Rejon Baltasy (Tatarstan) 413 Badania w Republice Tatarstanu
Włochy 7,74 Ciaramitaro et al.

Zróżnicowanie ze względu na wiek i płeć

Malformacja Chiari I może wystąpić w każdym wieku, jednak objawy najczęściej ujawniają się w dwóch przedziałach wiekowych: we wczesnym dzieciństwie (8-9 lat) oraz u dorosłych, ze szczytem występowania między 41 a 46 rokiem życia.1 Przyczyny tych szczytów zachorowalności nie są w pełni wyjaśnione.1

W populacji dorosłych obserwuje się wyraźną przewagę kobiet wśród pacjentów z malformacją Chiari I w stosunku 3:1.12 W badaniu przeprowadzonym w USA, wśród dorosłych pacjentów poddanych dekompresji z powodu MC-I, 78% stanowiły kobiety, podczas gdy wśród dzieci odsetek dziewczynek wynosił 53%.1 U dzieci proporcje płci są bardziej wyrównane.1

Interesujące jest, że mimo przewagi kobiet w większości badań, niektóre dane wskazują na odwrotną tendencję w określonych populacjach. Na przykład w Rosji, wśród Tatarów, zaobserwowano przewagę mężczyzn wśród pacjentów z objawową malformacją Chiari.12

Współwystępowanie z innymi schorzeniami

Malformacja Chiari często współwystępuje z innymi schorzeniami neurologicznymi, co ma istotne znaczenie dla nadzoru epidemiologicznego.12

Syringomielia (jamistość rdzenia) jest najczęstszym schorzeniem towarzyszącym malformacji Chiari I i występuje u około 20-56% pacjentów.12 Według badań Ciaramitaro, częstość występowania syringomielii w populacji ogólnej wynosi 4,84 na 100 000 osób (95% CI: 4,124-5,527), a zachorowalność 0,82 na 100 000 osób (95% CI: 0,599-1,137).1 W jednym z badań pediatrycznych syringomielię związaną z MC-I stwierdzono u 23% dzieci z MC-I, co stanowiło 0,83% całej badanej populacji.1

Wodogłowie występuje u około 7-10% pacjentów z malformacją Chiari I.12 Współwystępowanie wodogłowia z malformacją Chiari I jest niezależnym czynnikiem predykcyjnym powikłań po leczeniu chirurgicznym.1

Malformacja Chiari typu II niemal zawsze (około 95-100% przypadków) współwystępuje z przepukliną oponowo-rdzeniową (myelomeningocele).12 Warto zauważyć, że dzięki lepszej diagnostyce prenatalnej i profilaktyce (np. suplementacja kwasem foliowym w czasie ciąży), częstość występowania rozszczepu kręgosłupa, a tym samym malformacji Chiari II, zmniejsza się w wielu krajach.1

Anomalie kostne są obserwowane u około 23-45% pacjentów z malformacją Chiari I.12

Nadzór epidemiologiczny nad Malformacją Chiari

Wyzwania w monitorowaniu epidemiologicznym

Nadzór epidemiologiczny nad malformacją Chiari napotyka na szereg wyzwań, które utrudniają precyzyjne określenie skali problemu.12

Kluczowym problemem jest brak jednolitych kryteriów diagnostycznych. Różne badania stosują odmienne kryteria rozpoznania malformacji Chiari, co prowadzi do rozbieżności w szacunkach częstości występowania.12 Niektóre badania opierają się wyłącznie na radiologicznym kryterium przemieszczenia migdałków móżdżku o co najmniej 5 mm poniżej otworu wielkiego, inne uwzględniają również obecność objawów klinicznych.1

Znaczącym wyzwaniem jest duża liczba bezobjawowych przypadków. Wielu pacjentów z radiologicznymi cechami malformacji Chiari nie zgłasza żadnych objawów, co prowadzi do niedoszacowania rzeczywistej częstości występowania tej anomalii.12

Dostępność i powszechność badań obrazowych, szczególnie rezonansu magnetycznego, ma istotny wpływ na wykrywalność malformacji Chiari. W związku z rosnącą dostępnością MRI, coraz więcej przypadków jest wykrywanych przypadkowo podczas badań wykonywanych z innych wskazań.12

Aktualny stan badań epidemiologicznych

Badania epidemiologiczne dotyczące malformacji Chiari są w większości retrospektywne i często bazują na danych z pojedynczych ośrodków lub ograniczonych populacji.12 Brakuje dużych, prospektywnych badań epidemiologicznych zaprojektowanych specjalnie w celu określenia częstości występowania tej anomalii w populacji ogólnej.1

W Stanach Zjednoczonych przeprowadzono analizę pacjentów z malformacją Chiari I w okresie 14 lat, która wykazała, że 34% operacji dekompresyjnych wykonano u pacjentów poniżej 20 roku życia. Zaobserwowano również wzrost liczby operacji dekompresyjnych – o 51% u młodszych pacjentów i o 28% u dorosłych w drugiej połowie badanego okresu w porównaniu z pierwszą połową.1

Trwają badania mające na celu opracowanie bardziej precyzyjnych metod szacowania częstości występowania malformacji Chiari. Istotnym elementem tych badań jest analiza wpływu wieku na pozycję migdałków móżdżku, która zmienia się w ciągu życia – obniża się we wczesnym dzieciństwie, a następnie podnosi w wieku dorosłym.1

Znaczenie badań genetycznych i rodzinnych

Coraz więcej dowodów wskazuje na genetyczne podłoże malformacji Chiari, co ma istotne znaczenie dla nadzoru epidemiologicznego.12

Występowanie rodzinne malformacji Chiari, współwystępowanie u bliźniąt jednojajowych oraz współdziedziczenie ze znanymi zespołami genetycznymi silnie przemawiają za genetycznym podłożem tej anomalii.1 Badanie oparte na populacyjnym zasobie genealogicznym z powiązanymi danymi medycznymi, obejmujące 2871 pacjentów z malformacją Chiari I, dostarczyło silnych dowodów na genetyczną predyspozycję do MC-I.1

Mimo tych dowodów, dokładne warianty genetyczne odpowiedzialne za rozwój malformacji Chiari pozostają w większości przypadków nieznane.1 Prowadzone są różnorodne badania genetyczne wykorzystujące różne podejścia (analiza mutacji, analiza sprzężeń całego genomu, badania asocjacyjne, analiza ekspresji) w celu identyfikacji genetycznych cech leżących u podłoża tej choroby.1

Badania kliniczne i rejestry pacjentów

Istotnym elementem nadzoru epidemiologicznego nad malformacją Chiari są badania kliniczne i rejestry pacjentów.12

Według danych z ClinicalTrials.gov, przeprowadzono co najmniej 22 badania kliniczne dotyczące malformacji Chiari, w tym 1 aktywne, 11 zakończonych i 6 rekrutujących pacjentów.1 W bazach danych zidentyfikowano 737 czołowych ekspertów medycznych specjalizujących się w malformacji Chiari, w tym 690 lekarzy, działających w 37 krajach i 41 stanach USA.1

Firmy analityczne, takie jak DelveInsight, prowadzą badania rynkowe dotyczące malformacji Chiari, które obejmują analizę epidemiologiczną w głównych rynkach (USA, UE5 – Niemcy, Hiszpania, Włochy, Francja i Wielka Brytania, oraz Japonia).12 Celem tych badań jest dostarczenie historycznych i prognozowanych danych epidemiologicznych dotyczących malformacji Chiari w latach 2020-2034.1

Wyzwaniem w prowadzeniu badań klinicznych i rejestrów pacjentów z malformacją Chiari jest heterogenność tej choroby pod względem symptomatologii, epidemiologii i metod leczenia.1 W związku z tym, istnieje potrzeba opracowania bardziej precyzyjnych metod stratyfikacji pacjentów w celu lepszego zrozumienia naturalnego przebiegu choroby i optymalizacji metod leczenia.1

Prognozy i trendy przyszłych badań

Przyszłe kierunki badań epidemiologicznych dotyczących malformacji Chiari koncentrują się na kilku obszarach.12

Kluczowe znaczenie ma opracowanie i wdrożenie jednolitych kryteriów diagnostycznych, które umożliwią bardziej precyzyjne porównanie danych z różnych badań i regionów.1 Eksperci podkreślają potrzebę przeprowadzenia prospektywnych, dobrze zaprojektowanych badań na dużych populacjach, które dostarczą lepszych szacunków częstości występowania malformacji Chiari niż istniejące retrospektywne analizy baz danych organizacji opieki zdrowotnej.1

Istotnym kierunkiem jest pogłębienie zrozumienia naturalnego przebiegu choroby, szczególnie w przypadku bezobjawowych malformacji Chiari wykrytych przypadkowo. Badania wskazują, że u dzieci z MC-I bez syringomielii, które są bezobjawowe lub mają łagodne objawy, rokowanie jest na ogół dobre przy zachowawczym leczeniu, choć istnieje około 5% ryzyko konieczności operacji w przyszłości.12

Ważnym obszarem badań jest identyfikacja czynników predykcyjnych pozytywnych wyników leczenia chirurgicznego. Badacze z Emory wykorzystali rezonans magnetyczny do pomiaru objętości przepływu/udaru płynu mózgowo-rdzeniowego i odkryli, że przedoperacyjne pomiary dynamiki mózgowej lepiej przewidują poprawę przepływu płynu mózgowo-rdzeniowego i ruchomości mózgu po operacji niż konwencjonalny pomiar przedoperacyjnego przemieszczenia migdałków.1

Analiza bibliometryczna badań nad syringomielią związaną z malformacją Chiari ma na celu wypełnienie luki w wyczerpujących i obiektywnych opisach postępu badań w tej dziedzinie oraz identyfikację wschodzących tematów w ostatnich dwóch dekadach.1

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Chiari Syndrome: Advances in Epidemiology and Pathogenesis: A Systematic Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10607306/
    Arnold Chiari syndrome is a rare congenital disease of unknown prevalence and whose origin is still under study. […] The prevalence of this disease is unknown. Of the different types, CM-I is the most common, and its prevalence is estimated to be around 1 in 1000 births. […] The majority of published articles on Arnold Chiari Syndrome (ACS) agree that the prevalence of this condition is unknown and often underestimated; this could be attributed to the significant number of asymptomatic cases it presents. Some authors have tried to determine its prevalence. According to Ciaramitaro et al., the prevalence of CM in Italy is 7.74 CI 95% (6.9658.596), and its incidence is 3.08 CI 95% (2.6053.635). They also studied the incidence and prevalence of syringomyelia due to the high association with this syndrome, resulting in a prevalence of 4.84 CI 95% (4.1245.527) and an incidence of 0.82 CI 95% (0.5991.137).
  • #1 Epidemiology of Chiari I Malformation | SpringerLink
    https://link.springer.com/chapter/10.1007/978-3-030-44862-2_21
    Almost 1% of normal adults studied with magnetic resonance imaging (MRI) of the brain will have a finding of Chiari I malformation based on 5 mm or more of cerebellar tonsillar ectopia, while as many as 3.6% of normal children will have a Chiari I malformation finding using the same criteria. […] The proportion of adults with symptoms and MRI evidence of Chiari I malformation is estimated to be in the range of 0.010.04%. […] Symptoms of Chiari I malformation occurred in 0.007% of children in one study. […] Factors reported to increase the likelihood of developing Chiari I malformation include birth injury, trauma, pseudotumor cerebri, hydrocephalus, ancestry from a Pacific island, female gender in adults in the United States, and male gender in the Tatarstan, Russia. […] Going forward, more rigorous measurements of the prevalence and incidence of Chiari I malformation would result from prospective epidemiologic studies of large populations designed for this purpose than from retrospective queries of the databases of private and governmental healthcare organizations. […] Bogdanov EI, Faizutdinova AT, Mendelevich EG, Sozinov AS, Heiss JD. Epidemiology of symptomatic Chiari malformation in Tatarstan: regional and ethnic differences in prevalence.
  • #1 Chiari Malformation: Practice Essentials, Problem, Epidemiology
    https://emedicine.medscape.com/article/1483583-overview
    The most common Chiari malformation is type I and has been estimated to occur in 1 in 1000 births. The majority of these cases are asymptomatic. Chiari malformations are often detected coincidently among patients who have undergone diagnostic imaging for unrelated reasons. There is a slight female predominance of 1.3:1. Chiari II is associated with neural tube defects, particularly myelomeningocele, in around 100% of cases. […] Although Chiari malformation is still listed as a rare disease by the Office of Rare Diseases of the National Institutes of Health, this categorization is based on outdated data from before the MRI era. With routine use of MR imaging, Chiari malformation is discovered with increasing frequency. For Chiari I, prevalence rates of 0.1-0.5% with a slight female predominance have been suggested. Chiari II is found in all children with myelomeningocele, although less than one third develop symptoms referable to this malformation.
  • #1 Epidemiology of the Chiari I Malformation | SpringerLink
    https://link.springer.com/chapter/10.1007/978-1-4614-6369-6_6
    Almost 1 % of normal adults undergoing MRI scanning have cerebellar tonsillar ectopia of 5 mm or more, sufficient for radiographic diagnosis of Chiari I malformation (CM1). Only about 0.010.04 % of adults demonstrate symptoms and MRI evidence of CM1. […] Prospective well-designed studies of large populations will provide better estimates of CM1 prevalence than existing retrospective queries of the databases of private and governmental healthcare organizations. […] Factors predisposing to CM1 include an affected close relative, birth injury, trauma, pseudotumor cerebri, hydrocephalus, Pacific island ancestry, female gender in US adults, male gender in Russian Tartar adults, and possibly epigenetic changes.
  • #1 Epidemiology of Chiari Malformations in Children – ISPN Guide
    https://ispn.guide/congenital-disorders-of-the-nervous-system-in-children/chiari-malformations-in-children-homepage/epidemiology-of-chiari-malformations-in-children/
    Prevalence estimated at less than 1%: There are no population-based studies on the incidence or prevalence of Chiari malformations. From clinical series, prevalence has been estimated between 0.1 and 0.5%, but it is possible that higher rates could have resulted from more widespread recent use of MRI. Another study estimated a prevalence of 0.77% based on the total population of patients undergoing MRI of the head at a tertiary care center over a period of 3.5 years. Of these patients, 14% were clinically asymptomatic. […] 3.6% prevalence for radiographic Chiari I: In a pediatric study in which an 11-year brain MRI database of 14,116 children was studied, 509 patients (3.6%) met radiologic criteria for Chiari I malformation, with a mean tonsillar descent below the foramen magnum of 10.2 mm. Compared to previous work, this study comprised a much higher percentage of asymptomatic patients.
  • #1 Chiari Malformation and Syringomyelia, a pediatric clinical case review and discussion
    https://pediatriceducation.org/2025/04/21/what-symptoms-are-associated-with-syringomyelia-and-chiari-1-malformations/
    CM1 prevalence is estimated at 0.24% 3.6%, and symptomatic CM1 varies between 32-63%. […] One study of children estimated a prevalence of symptomatic CM1 at 7:100,000. […] Syr associated with CM1 was found to be 23% in one pediatric study or overall 0.83% of the study population. […] Another study estimated the prevalence of a symptomatic Syr at 4.84:100,000. […] The actual prevalence and incidence varies with different epidemiological studies which are prone to detection bias. […] Females are more likely to have CM1 and a Syr. […] Older pediatric age groups are more likely to have symptoms but that may also be due to difficulty of diagnosis in young children. […] In a 2021 review of the management of CM1 in children found that: Children with CM1 without Syr who were asymptomatic or mildly symptomatic generally had a benign prognosis and did well with conservative management.
  • #1 Developments in the treatment of Chiari type 1 malformations over the past decade – Passias – Journal of Spine Surgery
    https://jss.amegroups.org/article/view/4087/html
    CM-1 primary diagnoses have increased over time (45 to 96 per 100,000). […] The prevalence of CM-1 diagnoses has increased from 2003 to 2012, from 45 to 96 per 100,000 (P0.001). […] CM-1 diagnoses have increased in the last decade.
  • #1 Epidemiology | Neupsy Key
    https://neupsykey.com/epidemiology-5/
    The Tartar population in the Volga-Ural region of Russia, including Bashkortostan, Tatarstan and other areas, suffers from a particularly high prevalence of syringomyelia, at 130 per 100,000 inhabitants. […] The prevalence among both Tartars and other ethnic groups varied significantly across different regions of Tatarstan, ranging between 3.7 and 93 per 100,000 adults in Tartars and between 2 and 92 per 100,000 in a population composed mainly of Russians. […] Elsewhere in the world, the distribution of syringomyelia and related conditions, by country, region and even small territories, is extremely non-uniform (Table 2.3, Fig. 2.1). […] The high prevalence of syringomyelia in the north of Tatarstan may be associated not just with the predominance of the Tartar population in this region but also the employment of these people, mainly in physically demanding jobs in agriculture (authors own data).
  • #1
    https://journals.lww.com/neurosurgery/fulltext/2019/05000/epidemiology_of_symptomatic_chiari_malformation_in.13.aspx
    Epidemiology can assess the effect of Chiari I malformation (CM1) on the neurological health of a population and evaluate factors influencing CM1 development. […] The population of the Republic of Tatarstan (RT) in the Russian Federation was evaluated for patients with CM1 symptoms over an 11-yr period. […] MRI evidence of CM1, defined as cerebellar tonsils lying at least 5 mm inferior to the foramen magnum, was found in 67% of symptomatic patients. […] The period prevalence in the entire RT for symptomatic CM1 was 20:100 000; for bCM1 was 10:100 000; and for CM1 and bCM1 together was 30:100 000. […] Prevalence of patients with CM1 symptoms was greater in the northern than southern districts of Tatarstan, due to a high prevalence (413:100 000) of CM1 in the Baltasy region in one of the northern districts. […] A regional disease cluster of patients with Chiari malformation was found in Baltasy district of RT and needs further study.
  • #1 Chiari malformation and syringomyelia in: Journal of Neurosurgery: Spine Volume 31 Issue 5 (2019) Journals
    https://thejns.org/spine/view/journals/j-neurosurg-spine/31/5/article-p619.xml
    From a clinicians viewpoint, patients with Chiari anomalies present most frequently at two time periods: in early childhood (8 and 9 years) and in adults, with peak ages between 41 and 46 years.6 The reasons for these incidence peaks are not understood at the present time. There are, however, differences in treatment and treatment outcomes that apply to patients treated in early childhood and adult patients.
  • #1 Arnold-Chiari malformation epidemiology and demographics – wikidoc
    https://www.wikidoc.org/index.php/Arnold-Chiari_malformation_epidemiology_and_demographics
    The prevalence of Arnold Chiari malformation is unknown since most of the cases are accidentally found. […] It is believed that approximate prevalence is 0.1 to 0.5 percent worldwide. […] The mortality rate of Arnold Chiari malformation depends on the subtype. […] Type 3 has the highest mortality rate as a result of respiratory failure in infancy. […] Arnold Chiari malformation commonly affects adolescence and adulthood, but also has been seen in younger children. […] There is no racial predilection to Arnold Chiari malformation. […] Women are more commonly affected by Arnold Chiari malformation than men. The women to men ratio is approximately 3 to 1.
  • #1 Chiari Malformation: Practice Essentials, Problem, Epidemiology
    https://emedicine.medscape.com/article/1483583-overview
    In an analysis of patients with Chiari I over a 14-year period in the United States, 34% of Chiari I decompression operations were performed in patients younger than 20 years. Of adult patients who underwent decompression, 78% were female, whereas only 53% of children were female. The rate of decompression surgery increased 51% in younger patients from the first half to the second half of the study period and increased 28% in adult patients (20-65 yr of age).
  • #1 Epidemiology of Chiari Malformations in Children – ISPN Guide
    https://ispn.guide/congenital-disorders-of-the-nervous-system-in-children/chiari-malformations-in-children-homepage/epidemiology-of-chiari-malformations-in-children/
    All ages with majority diagnosed in late childhood: Although most patients with Chiari I malformation are diagnosed in late childhood to early adulthood, it is not uncommon for young children and older adults to present with symptoms. Since Chiari II malformation is associated with myelomeningocele, patients are diagnosed at birth. […] No difference: No population-based studies have been performed, but most clinical cohorts show equal incidence or a slight female predominance. […] No distribution apparent: There is no particular ethnic or geographic distribution. […] None known: There are no known risk factors, other than family history.
  • #1 Chiari I malformation | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/chiari-i-malformation?lang=us
    Chiari I malformations are more frequently encountered in females 1. […] Although Chiari I malformations are often isolated abnormalities, the following findings may be seen in association: cervical cord syrinx in ~35% (range 20-56%): more common in symptomatic patients, hydrocephalus in 7-10% of cases, the relationship remains poorly understood and whether the hydrocephalus or Chiari 1 malformation is the primary abnormality continues to be debated 12, abnormal CSF flow dynamics through the central canal of the cord and around the medulla, posterior fossa size, intracranial pressure and venous pressures have all been implicated as potentially contributory 13, skeletal anomalies in ~35% (range 23-45%) 2,3.
  • #1
    https://journals.lww.com/neur/fulltext/2021/69002/chiari_1_and_hydrocephalus___a_review.17.aspx
    Chiari 1 malformation (C1M) is commonly defined as a caudal displacement of the cerebellar tonsils exceeding 5 mm past the foramen magnum. This radiological finding is seen in 1% of the adult and up to 4% of the pediatric population and is rarely symptomatic, with asymptomatic isolated C1M having a relatively benign natural history. However, some patients with symptomatic C1M also present with hydrocephalus, diagnosed either before or after surgical decompression. The prevalence of hydrocephalus in patients with Chiari 1 malformations ranges from 6.5% to 9.6%, and comorbid hydrocephalus is an independent predictor of morbidity following surgical decompression. Clouding the clinical picture, the development of hydrocephalus following Chiari decompression is a known surgical complication, occurring in between 1% and 9% of operated patients in various case series. The association between hydrocephalus and Chiari malformations is more complicated than this theory suggests because treatment and resolution of hydrocephalus fail to improve hindbrain herniation or symptoms in many patients. Previous authors have suggested categorizing Chiari 1 malformation with hydrocephalus into groups based on their pathophysiology. We likewise propose categorizing Chiari 1 malformation-associated hydrocephalus into three groups in order to guide treatment planning: Hydrocephalus with secondary C1M, C1M with secondary hydrocephalus, and C1M with concurrent hydrocephalus. When encountering a patient with CIM and hydrocephalus, it is important to perform a thorough history and physical examination and augment this with sufficient imaging to make an educated guess as to the best initial course of action. A general approach to the treatment of Chiari 1 malformations with hydrocephalus is to treat the hydrocephalus with CSF diversion prior to suboccipital decompression.
  • #1 Chiari II malformation | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/chiari-ii-malformation?lang=us
    Chiari II malformations are commonly encountered, with an incidence of ~1:1000 live births. When a child is born with a myelomeningocele, the vast majority (~95%) have an associated Chiari II malformation. […] Chiari II malformations are relatively common congenital malformations of the spine and posterior fossa characterized by myelomeningocele (lumbosacral spina bifida aperta) and a small posterior fossa with descent of the brainstem, cerebellar tonsils, and vermis through the foramen magnum. Numerous associated abnormalities are also frequently encountered.
  • #1 Chiari malformation | Neurosurgery Inselspital Bern
    https://neurochirurgie.insel.ch/en/diseases-specialities/liquor-disorders/chiari-malformation
    Approximately 1% of all healthy adults who undergo magnetic resonance imaging (MRI) of the head show a caudal displacement of the cerebellar tonsils, that is, a displacement of parts of the cerebellum downwards into the foramen magnum and the spinal canal. […] However, only 0.01 to 0.04% of those affected show symptoms. […] Chiari malformation type II is an anomaly that occurs in about 1 of 1000 births and is a specific form of the disease. […] Due to improved prenatal diagnostics and preventive measures such as the intake of folic acid during pregnancy, the rate of spina bifida and thus also Chiari II malformation is declining in many countries.
  • #1 Decoding Chiari Malformation and Syringomyelia: From Epidemiology and Genetics to Advanced Diagnosis and Management Strategies
    https://www.mdpi.com/2076-3425/13/12/1658
    Chiari I malformation (CM) often coexists with a spinal cord syrinx. However, gauging the actual prevalence of CM and syrinx is challenging due to the absence of a flawless diagnostic tool applicable to the entire population. Instead, medical professionals often depend on approximations, primarily sourced from extensive retrospective studies examining brain and spinal imagery. […] Estimates suggest CM affects anywhere from 0.24% to 3.6% of individuals. This variance can be attributed to differences in the diagnostic sensitivity for CM and the diverse populations studied. […] Age plays a significant role in CM’s prevalence. Research indicates that CM is more commonly found in children. Notably, MRI scans reveal that the position of the cerebellar tonsil varies with age, descending during early life and rising again in adulthood.
  • #1 Genetic dissection of Chiari malformation type 1 using endophenotypes and stratification
    https://www.rarediseasesjournal.com/articles/genetic-dissection-of-chiari-malformation-type-1-using-endophenotypes-and-stratification.html
    Chiari malformation type 1 (CM-1) is the most prevalent form of the Chiari malformations, and is characterized by a downward herniation of the caudal part of the cerebellum through the foramen magnum into the upper cervical region. CM-1 is quite heterogeneous with respect to symptomatology, epidemiology and treatment. The incidence, prevalence and distribution of CM-1 is still unclear, and estimations vary depending on the criteria used to characterize the disease: TH criterion alone, TH criterion accompanied by symptomatology or a defining mechanism of the TH. For example, in the United States (US), almost 1 % of normal adults undergoing MRI scanning have at least 5mm of TH but only about 0.01-0.04 % of adults demonstrate symptoms of CM-1. Epidemiological data from other countries is generally missing. Moreover, in the US, estimates of the prevalence based on specific subtypes and/or comorbid conditions are scarce. Thus, the true prevalence of the condition, with respect to all forms of clinical heterogeneity is unknown.
  • #1 Genetic dissection of Chiari malformation type 1 using endophenotypes and stratification
    https://www.rarediseasesjournal.com/articles/genetic-dissection-of-chiari-malformation-type-1-using-endophenotypes-and-stratification.html
    The presence of multiplex families with several CM-1 cases, the co-occurrence of CM-1 in monozygotic twins and the co-inheritance with known genetic syndromes strongly argue for a genetic contribution to CM-1 pathogenicity. Despite this evidence, the precise genetic variants causative of the disease remain elusive in most cases. Several genetic studies, using different approaches (mutational analysis, whole genome linkage analysis, genetic association, expression analysis) have been performed in order to attempt to identify the genetic traits underlying this disease.
  • #1 Population-based description of familial clustering of Chiari malformation Type I in: Journal of Neurosurgery Volume 128 Issue 2 (2017) Journals
    https://thejns.org/view/journals/j-neurosurg/128/2/article-p460.xml
    A population-based genealogical resource with linked medical data was used to define the observed familial clustering of Chiari malformation Type I (CM-I). […] A total of 2871 patients with CM-I with at least 3 generations of genealogical data were identified. […] This population-based description of the familial clustering of 2871 patients with CM-I provided strong evidence for a genetic contribution to a predisposition to CM-I.
  • #1 Top Published Expert Doctors for Arnold-Chiari Malformation
    https://findexpertmd.com/d/Arnold-Chiari_Malformation
    737 top medical experts on Arnold-Chiari Malformation across 37 countries and 41 U.S. states, including 690 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants. […] Clinical Trials ClinicalTrials.gov: at least 22 including 1 Active, 11 Completed, 6 Recruiting.
  • #1 Chiari Malformation – Market Insight, Epidemiology, and Market Forecast – 2034
    https://www.giiresearch.com/report/del1506614-chiari-malformation-market-insight-epidemiology.html
    DelveInsight’s „Chiari Malformation – Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as the Chiari Malformation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. […] The Chiari Malformation epidemiology division provide insights about historical and current Chiari Malformation patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. […] The disease epidemiology covered in the report provides historical as well as forecasted Chiari Malformation epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.
  • #1 Research roundup: Recent publications from Emory faculty and staff
    https://news.emory.edu/stories/2025/hs_research_roundup_may_07-05-2025/story.html
    Emory researchers have found a promising new way to predict which patients with a certain congenital brain malformation would respond well to surgical intervention. […] The study was led by John Oshinski, PhD, professor of radiology and imaging sciences and biomedical engineering and Daniel Barrow, MD, professor of. […] The researchers used magnetic resonance imaging (MRI) to measure cerebrospinal fluid (CSF) flow/stroke volume, the amount of cerebrospinal fluid passing through the cerebral aqueduct during a heart cycle. […] An effective way to identify the conditions that would predict positive surgical outcomes is vital. […] The researchers found that presurgical measures of cerebral dynamics better predicted improvements to CSF flow and brain motion after surgery than the conventional measure of presurgical tonsillar descent. […] The team plans to validate the work through a larger clinical trial.
  • #1 Decoding Chiari Malformation and Syringomyelia: From Epidemiology and Genetics to Advanced Diagnosis and Management Strategies
    https://www.mdpi.com/2076-3425/13/12/1658
    Imaging studies offer the most accurate prevalence estimates for CM, especially when considering the many asymptomatic individuals who meet the imaging diagnostic criteria. Interestingly, females are more likely to have CM based on imaging results. They also tend to exhibit a lower position of the cerebellar tonsil across all ages when compared to males. […] In summary, CM prevalence differs across age and gender demographics. Truly estimating its occurrence within the general population remains a complex task. Ongoing research aims to gain a clearer understanding of how age impacts tonsil positioning and the related conditions to better grasp CM’s epidemiology. […] In studying Chiari malformation (CM) and associated disorders, temporal trends refer to the analysis of how the prevalence, incidence, or specific features of these conditions have transformed over various periods or generations.
  • #1 Decoding Chiari Malformation and Syringomyelia: From Epidemiology and Genetics to Advanced Diagnosis and Management Strategies
    https://www.mdpi.com/2076-3425/13/12/1658
    A substantial amount of research has been directed towards understanding the connections between syringomyelia and other diseases. However, there is a noticeable deficit in exhaustive and unbiased accounts of the research progress of syringomyelia. The present study endeavored to perform a bibliometric analysis to bridge this gap, charting the research trajectory of syringomyelia and identifying emergent themes over the past two decades.
  • #2 Chiari malformation and syringomyelia in: Journal of Neurosurgery: Spine Volume 31 Issue 5 (2019) Journals
    https://thejns.org/spine/view/journals/j-neurosurg-spine/31/5/article-p619.xml
    Chiari malformation was first described over a century ago, and consists of posterior fossa anomalies that generally share the feature of cerebellar tonsillar descent through the foramen magnum. […] Although the number of patients with the imaging diagnosis of Chiari anomaly has increased greatly since the availability of MRI, the true incidence of clinically significant Chiari anomalies is considerably lower. This is the result of varying criteria used by radiologists to make a diagnosis of Chiari anomaly, as well as the problem of estimating the prevalence of Chiari anomaly on the select group of individuals undergoing imaging. The prevalence has been cited as 0.24%3.6% of the population,43 and 0.56%0.77% based on MRI studies.6,53 The true incidence of the structural abnormalities forming the diagnostic criteria of Chiari anomaly in the population is presumably much higher because there undoubtedly are many individuals who remain asymptomatic, even though they have structural abnormalities typical of the Chiari anomaly.
  • #2 Decoding Chiari Malformation and Syringomyelia: From Epidemiology and Genetics to Advanced Diagnosis and Management Strategies
    https://www.mdpi.com/2076-3425/13/12/1658
    Chiari I malformation (CM) often coexists with a spinal cord syrinx. However, gauging the actual prevalence of CM and syrinx is challenging due to the absence of a flawless diagnostic tool applicable to the entire population. Instead, medical professionals often depend on approximations, primarily sourced from extensive retrospective studies examining brain and spinal imagery. […] Estimates suggest CM affects anywhere from 0.24% to 3.6% of individuals. This variance can be attributed to differences in the diagnostic sensitivity for CM and the diverse populations studied. […] Age plays a significant role in CM’s prevalence. Research indicates that CM is more commonly found in children. Notably, MRI scans reveal that the position of the cerebellar tonsil varies with age, descending during early life and rising again in adulthood.
  • #2 Genetic dissection of Chiari malformation type 1 using endophenotypes and stratification
    https://www.rarediseasesjournal.com/articles/genetic-dissection-of-chiari-malformation-type-1-using-endophenotypes-and-stratification.html
    Chiari malformation type 1 (CM-1) is the most prevalent form of the Chiari malformations, and is characterized by a downward herniation of the caudal part of the cerebellum through the foramen magnum into the upper cervical region. CM-1 is quite heterogeneous with respect to symptomatology, epidemiology and treatment. The incidence, prevalence and distribution of CM-1 is still unclear, and estimations vary depending on the criteria used to characterize the disease: TH criterion alone, TH criterion accompanied by symptomatology or a defining mechanism of the TH. For example, in the United States (US), almost 1 % of normal adults undergoing MRI scanning have at least 5mm of TH but only about 0.01-0.04 % of adults demonstrate symptoms of CM-1. Epidemiological data from other countries is generally missing. Moreover, in the US, estimates of the prevalence based on specific subtypes and/or comorbid conditions are scarce. Thus, the true prevalence of the condition, with respect to all forms of clinical heterogeneity is unknown.
  • #2 Chiari I Malformation (CMI) Imaging: Practice Essentials, Radiography, Computed Tomography
    https://emedicine.medscape.com/article/406849-overview
    Evaluation by Davidson et al of a large group of patients with incidentally discovered Chiari I malformations demonstrated that most patients can be managed conservatively, especially in the absence of syringomyelia. […] With the widespread availability and use of MRI, incidental Chiari I malformation is now more commonly recognized.
  • #2 Chiari Malformation – UChicago Medicine
    https://www.uchicagomedicine.org/conditions-services/neurology-neurosurgery/congenital-anomalies/chiari-malformation
    In children, CM occurs equally in boys and girls. In adults, it is three times more common in women than men. Family history also increases the risk of CM. […] Chiari malformation is evaluated with a medical history and physical exam along with imaging tests such as MRI and/or CT scan.
  • #2 Epidemiology of the Chiari I Malformation | SpringerLink
    https://link.springer.com/chapter/10.1007/978-1-4614-6369-6_6
    Almost 1 % of normal adults undergoing MRI scanning have cerebellar tonsillar ectopia of 5 mm or more, sufficient for radiographic diagnosis of Chiari I malformation (CM1). Only about 0.010.04 % of adults demonstrate symptoms and MRI evidence of CM1. […] Prospective well-designed studies of large populations will provide better estimates of CM1 prevalence than existing retrospective queries of the databases of private and governmental healthcare organizations. […] Factors predisposing to CM1 include an affected close relative, birth injury, trauma, pseudotumor cerebri, hydrocephalus, Pacific island ancestry, female gender in US adults, male gender in Russian Tartar adults, and possibly epigenetic changes.
  • #2 Chiari I Malformation (CMI) Imaging: Practice Essentials, Radiography, Computed Tomography
    https://emedicine.medscape.com/article/406849-overview
    Chiari I malformation, or Chiari malformation type I (CMI), is the most common, having been estimated to occur in 1 in 1000 births. […] CMI is more common in females. […] Chiari I malformation is usually an isolated abnormality, but it can be associated with other abnormalities, including cervical cord syrinx (20%56% cases), hydrocephalus (7%10% cases), and skeletal anomalies (23%45 % cases). […] Incidental finding of Chiari I malformation in asymptomatic patients on MRI does not require routine followup imaging. […] In symptomatic patients, CSF velocity at the craniovertebral junction (CVJ) is known to be altered. […] Although the association of Chiari I malformation with cranial and vertebral anomalies is well known, this condition is not directly associated with other neuroectodermal abnormalities (ie phakomatoses).
  • #2 Chiari Malformation: Practice Essentials, Problem, Epidemiology
    https://emedicine.medscape.com/article/1483583-overview
    The most common Chiari malformation is type I and has been estimated to occur in 1 in 1000 births. The majority of these cases are asymptomatic. Chiari malformations are often detected coincidently among patients who have undergone diagnostic imaging for unrelated reasons. There is a slight female predominance of 1.3:1. Chiari II is associated with neural tube defects, particularly myelomeningocele, in around 100% of cases. […] Although Chiari malformation is still listed as a rare disease by the Office of Rare Diseases of the National Institutes of Health, this categorization is based on outdated data from before the MRI era. With routine use of MR imaging, Chiari malformation is discovered with increasing frequency. For Chiari I, prevalence rates of 0.1-0.5% with a slight female predominance have been suggested. Chiari II is found in all children with myelomeningocele, although less than one third develop symptoms referable to this malformation.
  • #2 Chiari Malformation – AANS
    https://www.aans.org/patients/conditions-treatments/chiari-malformation/
    The prevalence in the general population has been estimated at slightly less than one in 1000. The majority of these cases are asymptomatic. Chiari malformations are often detected coincidently among patients who have undergone diagnostic imaging for unrelated reasons. […] Treatment of Chiari malformations and syringomyelia is very dependent on the exact type of malformation, as well as progression in anatomy changes or symptoms.
  • #2 Chiari Malformation: What It Is, Symptoms, Types & Treatment
    https://my.clevelandclinic.org/health/diseases/6008-chiari-malformation
    Studies suggest that Chiari malformations occur in about 1 in every 1,000 people in the United States. […] Chiari malformations are almost always present at birth (congenital), though symptoms may not develop until later in life. […] A Chiari malformation can affect anyone. You may be more likely to develop a Chiari malformation if someone in your biological family has the condition.
  • #2 Chiari Malformation – Market Insight, Epidemiology, and Market Forecast – 2034
    https://www.giiresearch.com/report/del1506614-chiari-malformation-market-insight-epidemiology.html
    DelveInsight’s „Chiari Malformation – Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as the Chiari Malformation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. […] The Chiari Malformation epidemiology division provide insights about historical and current Chiari Malformation patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. […] The disease epidemiology covered in the report provides historical as well as forecasted Chiari Malformation epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.
  • #2 Chiari Malformation – Market Insight, Epidemiology, and Market Forecast – 2034
    https://www.giiresearch.com/report/del1506614-chiari-malformation-market-insight-epidemiology.html
    The epidemiology segment also provides the Chiari Malformation epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. […] What is the historical Chiari Malformation patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan? […] What would be the forecasted patient pool of Chiari Malformation in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan? […] Out of all 7MM countries, which country would have the highest prevalent population of Chiari Malformation during the forecast period (2020-2034)?
  • #2 Decoding Chiari Malformation and Syringomyelia: From Epidemiology and Genetics to Advanced Diagnosis and Management Strategies
    https://www.mdpi.com/2076-3425/13/12/1658
    A substantial amount of research has been directed towards understanding the connections between syringomyelia and other diseases. However, there is a noticeable deficit in exhaustive and unbiased accounts of the research progress of syringomyelia. The present study endeavored to perform a bibliometric analysis to bridge this gap, charting the research trajectory of syringomyelia and identifying emergent themes over the past two decades.
  • #2 Chiari Malformation and Syringomyelia, a pediatric clinical case review and discussion
    https://pediatriceducation.org/2025/04/21/what-symptoms-are-associated-with-syringomyelia-and-chiari-1-malformations/
    These children did need to be followed as there was about a 5% risk of needing surgery in the future. […] Children with CM1 with and without Syr who were significantly symptomatic were small in number and overall if they underwent surgery did well. […] Syr with an identifiable cause should have that cause addressed. […] Syr without CM1 was rare but generally these patient seemed to do well overtime without conservative management. […] Holste KG, Muraszko KM, Maher CO. Epidemiology of Chiari I Malformation and Syringomyelia. Neurosurgery Clinics of North America. 2023;34(1):9-15. doi:10.1016/j.nec.2022.08.001
  • #3 Epidemiology of Chiari Malformations in Children – ISPN Guide
    https://ispn.guide/congenital-disorders-of-the-nervous-system-in-children/chiari-malformations-in-children-homepage/epidemiology-of-chiari-malformations-in-children/
    Prevalence estimated at less than 1%: There are no population-based studies on the incidence or prevalence of Chiari malformations. From clinical series, prevalence has been estimated between 0.1 and 0.5%, but it is possible that higher rates could have resulted from more widespread recent use of MRI. Another study estimated a prevalence of 0.77% based on the total population of patients undergoing MRI of the head at a tertiary care center over a period of 3.5 years. Of these patients, 14% were clinically asymptomatic. […] 3.6% prevalence for radiographic Chiari I: In a pediatric study in which an 11-year brain MRI database of 14,116 children was studied, 509 patients (3.6%) met radiologic criteria for Chiari I malformation, with a mean tonsillar descent below the foramen magnum of 10.2 mm. Compared to previous work, this study comprised a much higher percentage of asymptomatic patients.